Open AccessClinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Author(s) -
Sudeb C. Dalai,
Jennifer N. Dines,
Thomas M. Snyder,
Rachel Gittelman,
Tera Eerkes,
Pashmi Vaney,
Sally Howard,
Kipp Akers,
Lynell R. Skewis,
Anthony Monteforte,
Pamela R Witte,
Cristina Wolf,
Hans Nesse,
Megan Herndon,
Jia Qadeer,
Sarah Q. Duffy,
Emily Svejnoha,
Caroline Taromino,
Ian M. Kaplan,
John P. Alsobrook,
Thomas Manley,
Lance Baldo
Publication year - 2022
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac353
Subject(s) - medicine , serology , immunology , coronavirus , middle east respiratory syndrome coronavirus , virology , polymerase chain reaction , antibody , covid-19 , disease , biology , infectious disease (medical specialty) , gene , biochemistry
While diagnostic, therapeutic, and vaccine development in the coronavirus disease 2019 (COVID-19) pandemic has proceeded at unprecedented speed, critical gaps in our understanding of the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain unaddressed by current diagnostic strategies.